VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 175 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $719,000 | -40.4% | 28,214 | -39.9% | 0.05% | -21.7% |
Q1 2022 | $1,207,000 | -38.5% | 46,914 | 0.0% | 0.07% | -31.0% |
Q4 2021 | $1,964,000 | -4.2% | 46,914 | -0.4% | 0.10% | -10.7% |
Q3 2021 | $2,050,000 | -9.2% | 47,095 | -1.3% | 0.11% | -9.7% |
Q2 2021 | $2,257,000 | -7.8% | 47,739 | 0.0% | 0.12% | -16.2% |
Q1 2021 | $2,448,000 | +86.7% | 47,739 | -2.5% | 0.15% | +92.2% |
Q4 2020 | $1,311,000 | -22.0% | 48,973 | 0.0% | 0.08% | -32.5% |
Q3 2020 | $1,681,000 | – | 48,973 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |